Dr. Jones is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6655 Travis St, Suite 320
Houston, TX 77030
Education & Training
- Baylor College of MedicineResidency, Internal Medicine, 1977 - 1981
- Baylor College of MedicineClass of 1977
Certifications & Licensure
- TX State Medical License 1977 - 2024
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Master of the National Lipid Association NLA, 2022
- Chief Science Officer National Lipid Association, 2013-2019
Publications & Presentations
PubMed
- 157 citationsUse of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association.Don P Wilson, Terry A Jacobson, Peter H Jones, Marlys L Koschinsky, Catherine J McNeal
Journal of Clinical Lipidology. 2022-08-26 - 8 citationsGreater than expected reduction in low-density lipoprotein-cholesterol (LDL-C) with bempedoic acid in a patient with heterozygous familial hypercholesterolemia (HeFH).Ali M. Agha, Peter B. Jones, Christie M. Ballantyne, Salim S. Virani, Vijay Nambi
Journal of Clinical Lipidology. 2021-07-10 - 6 citationsA Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 StudiesMichael J. Koren, Peter B. Jones, Jennifer G. Robinson, David R. Sullivan, Leslie Cho
Cardiology and Therapy. 2020-06-20
Journal Articles
- Alirocumab Safety in People with and Without Diabetes Mellitus: Pooled Data from 14 ODYSSEY TrialsD G Karalis, P H Jones, Diabetic Medicine
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: